Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Bacil Pharma Ltd

NSE: BACPHAR · BSE: 524516 · Pharmaceuticals & Biotechnology · 25 announcements

Share price
₹26.39
Market cap
₹37.88 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹1.56 Cr
P/E (TTM)
57.8×Sector 47.4×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:42 IST BSE
Board Meeting Date

Bacil Pharma Board Meeting Date

Bacil Pharma Limited has scheduled a board meeting for August 29, 2026, to discuss and approve the notice and scheduling of its 39th Annual General Meeting.

22:54 IST BSE
Board Meeting Date

Bacil Pharma Board Meeting Date

Bacil Pharma Ltd has scheduled a Board Meeting for August 25, 2026. The agenda includes the discussion on the appointment of directors.

19:32 IST BSE
Board Meeting Date

Bacil Pharma Board Meeting Date

Bacil Pharma Limited has scheduled a board meeting for August 12, 2026, to consider and approve the unaudited financial results for the quarter ending June 30, 2026.

18:53 IST BSE
Board Meeting Date

Bacil Pharma Board Meeting Date

Bacil Pharma Ltd will hold a Board Meeting on 9th July 2026 to consider a rights issue of up to ₹50 Crore. Trading window will remain closed until 48 hours after the meeting.

17:19 IST BSE
Board Meeting Date

Bacil Pharma Board Meeting Date

Bacil Pharma Limited scheduled a board meeting for May 22, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.